Mayo Clinic Proceedings: Impact of a High-Risk, Ambulatory COVID-19 Remote Patient Monitoring Program on Utilization, Cost, and Mortality

Mayo Clinic Proceedings: Impact of a High-Risk, Ambulatory COVID-19 Remote Patient Monitoring Program on Utilization, Cost, and Mortality

The Mayo Clinic conducted a retrospective analysis that included patients diagnosed with COVID-19 at risk for severe disease who enrolled in the health system’s remote patient monitoring (RPM) program between March 2020 – October 2021. The program included in-home technology for symptom and physiologic data monitoring with centralized care management. High-risk COVID-19 patients enrolled and engaged in an RPM program experienced lower rates of hospitalization, ICU admission, mortality, and cost than those enrolled and not engaged in such programs. These findings translate to improved hospital bed access and patient outcomes.